MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation
Journal Article

Monocyte–platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation

2016
Request Book From Autostore and Choose the Collection Method
Overview
Background A strong interdependence is known between atrial fibrillation (AF), inflammation and thrombogenesis. Monocyte–platelet aggregates (MPAs) are sensitive markers of platelets and monocyte activation. It is not known whether MPAs are associated with thrombogenicity in AF. Therefore, we examined differences in the content of MPAs and CD11b expression in patients with AF in dependence of the presence of atrial thrombus formation. Methods 107 patients with symptomatic AF underwent transesophageal echocardiography (TEE) before planned cardioversion or pulmonary vein isolation. Flow-cytometric quantification analysis was done on the day of performed TEE to determine the content of MPAs and the expression of CD11b on monocytes and granulocytes. Results Compared to patients without thrombus ( n  = 80) those with an echocardiographic proven left atrium (LA) thrombus ( n  = 27) showed an increased extent of the risk factors age, diabetes and heart failure. The content of MPAs (147 ± 12 vs. 311 ± 29 cells/µl, p  < 0.001) as well as the CD11b expression on monocytes ( p  < 0.05) and granulocytes ( p  < 0.05) were strongly associated with the existence of a LA thrombus. The content of MPAs and the CD11b expression remained independent predictors for LA thrombus after adjustment in logistic regression analysis and negatively correlated with left atrial appendage flow velocity. MPAs above 170 cells/µl (OR 34.2, p  = 0.01) had a sensitivity of 96 % and a specificity of 73 % for predicting LA-thrombus. Conclusions The content of MPAs and the CD11b expression on monocytes and granulocytes are increased in AF-patients with proven thrombus formation. They seem to be appropriate biomarkers for stratification of thromboembolic risk in patients with AF.